SCIENTIFIC PUBLICATIONS

Our medical oncologists and laboratory investigators are at the forefront of investigations into the causes of cancer and the search for novel treatments.

We have published the results of our investigations, often in collaboration with some of the most prestigious international institutions, in renowned medical journals such as the New England Journal of Medicine, Clinical Cancer Research, and many others.

CONSULT OUR SCIENTIFIC PUBLICATIONS

01/11/2014

Lungscape: resected non–small-cell lung cancer outcome by clinical and pathological parameters

AUTHORS Lungscape investigators inc. Rosell R

PUBLICATION Journal of Thoracic Oncology

READ ARTICLE

01/09/2014

Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non–small cell lung cancer

AUTHORS Miguel A. Molina-Vila, Jordi Bertran-Alamillo, Amaya Gascó, Clara Mayo-de-las-Casas, María Sánchez-Ronco, Laia Pujantell-Pastor, Laura Bonanno, Adolfo G. Favaretto, Andrés F. Cardona, Alain Vergnenègre, et al. & Santiago Viteri, Rafael Rosell

PUBLICATION Clinical Cancer Research

READ ARTICLE

01/09/2014

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project

AUTHORS Fiona H. Blackhall, Solange Peters, Lukas Bubendorf, Urania Dafni, Keith M. Kerr, Henrik Hager, Alex Soltermann, Kenneth J. O'Byrne, Christoph Dooms, Aleksandra Sejda, Javier Hernández-Losa, Antonio Marchetti, et al & Rafael Rosell, Rolf Stahel

PUBLICATION Journal of Clinical Oncology

READ ARTICLE

27/08/2014

Two biomarker-directed randomized trials in European and Chinese patients with non-small-cell lung cancer: The BRCA1-RAP80 Expression Customization (BREC) studies

AUTHORS T. Moran, J. Wei, M. Cobo, X. Qian, M. Domine, Z. Zou, I. Bover, L. Wang, M. Provencio, L. Yu, I. Chaib, C. You, B. Massuti, Y. Song, A. Vergnenegre, H. Lu, G. Lopez-Vivanco, W. Hu, G. Robinet, J. Yan, A. et al. & Rosell R

PUBLICATION Annals of Oncology

READ ARTICLE

27/08/2014

What new therapeutic targets exist for EGFR-mutant NSCLC?

AUTHORS Rosell R

PUBLICATION The Lancet Oncology

READ ARTICLE